Enimmune corporation (TPEX:6564)
Taiwan · Delayed Price · Currency is TWD 20.90
+0.40 (1.95%)
Jan 22, 2026, 12:13 PM CST
Enimmune corporation Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 42.23 | 39.92 | 43.49 | 188.42 | 109.82 | 22.88 | Upgrade | |
Revenue Growth (YoY) | -16.90% | -8.23% | -76.92% | 71.56% | 380.07% | 1076.75% | Upgrade |
Cost of Revenue | 28.06 | 25.69 | 66.87 | 167.57 | 71.1 | 14.66 | Upgrade |
Gross Profit | 14.18 | 14.23 | -23.37 | 20.84 | 38.72 | 8.22 | Upgrade |
Selling, General & Admin | 81.83 | 80.57 | 80.66 | 54.96 | 42.57 | 32.09 | Upgrade |
Research & Development | 120.75 | 84.95 | 139.27 | 247.38 | 54.76 | 58.85 | Upgrade |
Operating Expenses | 200.86 | 165.37 | 220.1 | 307.26 | 97.39 | 90.94 | Upgrade |
Operating Income | -186.68 | -151.14 | -243.48 | -286.42 | -58.67 | -82.72 | Upgrade |
Interest Expense | -3.04 | -2.2 | -0.98 | -0.32 | -0.23 | -0.18 | Upgrade |
Interest & Investment Income | 3.22 | 2.58 | 1.94 | 1.29 | 2.39 | 1.68 | Upgrade |
Currency Exchange Gain (Loss) | -0.09 | -0.6 | -0.34 | 7.45 | 0.01 | - | Upgrade |
Other Non Operating Income (Expenses) | 18.71 | -14.21 | 5.16 | 10.9 | 9.25 | 6.77 | Upgrade |
Pretax Income | -167.88 | -165.57 | -237.69 | -267.09 | -47.25 | -74.45 | Upgrade |
Earnings From Continuing Operations | -167.88 | -165.57 | -237.69 | -267.09 | -47.25 | -74.45 | Upgrade |
Minority Interest in Earnings | 3.14 | 8.03 | 13.95 | 19.12 | - | - | Upgrade |
Net Income | -164.74 | -157.55 | -223.74 | -247.96 | -47.25 | -74.45 | Upgrade |
Net Income to Common | -164.74 | -157.55 | -223.74 | -247.96 | -47.25 | -74.45 | Upgrade |
Shares Outstanding (Basic) | 74 | 72 | 66 | 64 | 60 | 53 | Upgrade |
Shares Outstanding (Diluted) | 74 | 72 | 66 | 64 | 60 | 53 | Upgrade |
Shares Change (YoY) | 11.58% | 8.70% | 3.03% | 6.44% | 12.50% | 21.21% | Upgrade |
EPS (Basic) | -2.22 | -2.20 | -3.40 | -3.88 | -0.79 | -1.40 | Upgrade |
EPS (Diluted) | -2.22 | -2.20 | -3.40 | -3.88 | -0.79 | -1.40 | Upgrade |
Free Cash Flow | -168.41 | -144.25 | -138.13 | -200.98 | -74.53 | -111.61 | Upgrade |
Free Cash Flow Per Share | -2.27 | -2.02 | -2.10 | -3.15 | -1.24 | -2.09 | Upgrade |
Gross Margin | 33.56% | 35.64% | -53.74% | 11.06% | 35.26% | 35.93% | Upgrade |
Operating Margin | -442.04% | -378.66% | -559.79% | -152.01% | -53.42% | -361.61% | Upgrade |
Profit Margin | -390.08% | -394.70% | -514.42% | -131.60% | -43.02% | -325.46% | Upgrade |
Free Cash Flow Margin | -398.77% | -361.39% | -317.59% | -106.67% | -67.86% | -487.89% | Upgrade |
EBITDA | -181.01 | -145.53 | -237.71 | -280.06 | -50.19 | -75.77 | Upgrade |
EBITDA Margin | - | - | - | -148.64% | -45.70% | - | Upgrade |
D&A For EBITDA | 5.67 | 5.61 | 5.77 | 6.35 | 8.49 | 6.95 | Upgrade |
EBIT | -186.68 | -151.14 | -243.48 | -286.42 | -58.67 | -82.72 | Upgrade |
EBIT Margin | - | - | - | -152.01% | -53.42% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.